RET Trademark

Trademark Overview

On Wednesday, January 27, 2021, a trademark application was filed for RET with the United States Patent and Trademark Office. The USPTO has given the RET trademark a serial number of 90492436. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, November 15, 2024. This trademark is owned by Eli Lilly and Company. The RET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer

General Information

Serial Number90492436
Word MarkRET
Filing DateWednesday, January 27, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, November 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 29, 2021
Primary Code005
First Use Anywhere DateTuesday, September 3, 2024
First Use In Commerce DateTuesday, September 3, 2024

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Saturday, January 30, 2021NEW APPLICATION ENTERED
Thursday, April 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 3, 2021ASSIGNED TO EXAMINER
Thursday, June 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 23, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Tuesday, July 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 7, 2022SOU TEAS EXTENSION RECEIVED
Monday, February 7, 2022SOU EXTENSION 1 FILED
Monday, February 7, 2022SOU EXTENSION 1 GRANTED
Wednesday, February 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 11, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 11, 2022SOU EXTENSION 2 FILED
Thursday, August 11, 2022SOU EXTENSION 2 GRANTED
Saturday, August 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 8, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 8, 2023SOU EXTENSION 3 FILED
Wednesday, February 8, 2023SOU EXTENSION 3 GRANTED
Friday, February 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 3, 2023SOU EXTENSION 4 FILED
Thursday, August 3, 2023SOU EXTENSION 4 GRANTED
Saturday, August 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024SOU EXTENSION 5 GRANTED
Tuesday, February 13, 2024SOU EXTENSION 5 FILED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 4, 2024USE AMENDMENT FILED
Wednesday, September 4, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, November 5, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 5, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 15, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, November 15, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Related Keywords

pharmaceutical preparations cancer namely treatment